1. Home
  2. PODD vs PHG Comparison

PODD vs PHG Comparison

Compare PODD & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • PHG
  • Stock Information
  • Founded
  • PODD 2000
  • PHG 1891
  • Country
  • PODD United States
  • PHG Netherlands
  • Employees
  • PODD N/A
  • PHG N/A
  • Industry
  • PODD Medical/Dental Instruments
  • PHG Medical Electronics
  • Sector
  • PODD Health Care
  • PHG Health Care
  • Exchange
  • PODD Nasdaq
  • PHG Nasdaq
  • Market Cap
  • PODD 22.1B
  • PHG 26.0B
  • IPO Year
  • PODD 2007
  • PHG N/A
  • Fundamental
  • Price
  • PODD $325.91
  • PHG $29.03
  • Analyst Decision
  • PODD Strong Buy
  • PHG Strong Buy
  • Analyst Count
  • PODD 19
  • PHG 1
  • Target Price
  • PODD $346.95
  • PHG N/A
  • AVG Volume (30 Days)
  • PODD 536.4K
  • PHG 1.0M
  • Earning Date
  • PODD 11-06-2025
  • PHG 11-04-2025
  • Dividend Yield
  • PODD N/A
  • PHG 2.91%
  • EPS Growth
  • PODD N/A
  • PHG N/A
  • EPS
  • PODD 3.45
  • PHG 0.21
  • Revenue
  • PODD $2,521,800,000.00
  • PHG $20,861,199,111.00
  • Revenue This Year
  • PODD $29.32
  • PHG $0.67
  • Revenue Next Year
  • PODD $18.37
  • PHG $3.08
  • P/E Ratio
  • PODD $93.51
  • PHG $138.16
  • Revenue Growth
  • PODD 27.11
  • PHG N/A
  • 52 Week Low
  • PODD $230.05
  • PHG $21.48
  • 52 Week High
  • PODD $353.50
  • PHG $29.29
  • Technical
  • Relative Strength Index (RSI)
  • PODD 54.90
  • PHG 62.47
  • Support Level
  • PODD $311.51
  • PHG $27.90
  • Resistance Level
  • PODD $335.00
  • PHG $28.53
  • Average True Range (ATR)
  • PODD 10.85
  • PHG 0.59
  • MACD
  • PODD 0.57
  • PHG 0.06
  • Stochastic Oscillator
  • PODD 78.61
  • PHG 91.92

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About PHG Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Share on Social Networks: